Related Experiment Video
Updated: Jan 22, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
Published on: July 20, 2022
Update of the European consensus on sarcopenia: what has changed in diagnosis and prevalence in peritoneal dialysis?
Maryanne Zilli Canedo da Silva1, Barbara Perez Vogt2, Nayrana Soares do Carmo Reis1
1Universidade Estadual Paulista (UNESP), Department of Internal Medicine, Faculdade de Medicina de Botucatu, Botucatu, Brazil.
Abstract:
Patients on peritoneal dialysis (PD) may be affected by sarcopenia, which is a progressive and generalized skeletal muscle disorder characterized by muscle mass atrophy with decline of muscle strength and function. The aim was to evaluate differences in the diagnosis and prevalence of sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP). The screening for sarcopenia was performed in PD patients older than 18 years, with evaluation of appendicular skeletal muscle mass index (ASMMI), handgrip strength (HGS) and gait speed (GS). The diagnosis was according to the 2010 and 2019 versions of EWGSOP consensus on sarcopenia. Fifty subjects on PD were included, mean age 55.74 ± 16.22 years old, 52% female. The prevalence of sarcopenia ranged from 4 to 10% according to cut points and references used.
Related Concept Videos
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis III: Nursing Management
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Dialysis

